PBM Contracts Should Focus On Net Cost, Not Rebates, Express Scripts Says
Executive Summary
Drug plans should focus on PBMs' abilities to lower overall net cost of prescriptions, rather than try to get a share of manufacturer rebates, Express Scripts Senior VP Thomas Boudreau told a Federal Trade Commission hearing on health care competition June 26 in Washington, D.C